KYOWA KIRIN CO. LTD./ JP3256000005 /
| 8/15/2024 11:43:34 AM | Chg. -0.200 | Volume | Bid8/15/2024 | Ask8/15/2024 | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 18.600EUR | -1.06% | - Turnover: - |
18.500Bid Size: 133 | 19.100Ask Size: 133 | 10.17 bill.EUR | - | - |
GlobeNewswire
6/28
Ardelyx Presents Additional Data Detailing Educational Needs Related to IBS-C Management Across Heal...
GlobeNewswire
6/28
Orchard Therapeutics Celebrates Global Progress toward Advancing Newborn Screening for MLD on Intern...
GlobeNewswire
6/13
Xilio Therapeutics Appoints Aoife Brennan, M.D., and James Shannon, M.D., to its Board of Directors
GlobeNewswire
5/23
Hornet Therapeutics emerges from stealth with data published in Science demonstrating the first pote...
GlobeNewswire
5/21
Ardelyx Presents Additional Data at the 2024 Digestive Disease Week Conference on IBSRELA® (tenapano...
GlobeNewswire
5/16
Ardelyx Presents Additional Data at the NKF 2024 Spring Clinical Meetings on XPHOZAH® (tenapanor)
GlobeNewswire
5/8
Pharming Group reports first quarter 2024 financial results and provides business update
GlobeNewswire
5/7
Ardelyx to Present Additional Data Supporting First-In-Class IBSRELA® (tenapanor) for Adults with Ir...
GlobeNewswire
5/3
Orchard Therapeutics Co-founder and Chief Executive Officer Dr. Bobby Gaspar Named to Inaugural 2024...
GlobeNewswire
5/1
Ardelyx to Present Additional Data Supporting First-In-Class XPHOZAH® (tenapanor) for Adults with Ch...
GlobeNewswire
4/23
AVEROA Submits Marketing Authorisation Application to the European Medicines Agency Seeking Approval...
GlobeNewswire
4/10
Oculis Strengthens its Executive Leadership Team with the Appointment of Snehal Shah, Pharm.D. as Pr...
GlobeNewswire
3/25
Ardelyx Appoints Veteran BioPharma Executive, Mike Kelliher, as Executive Vice President, Corporate ...
